Press release
Post-operative Cataract Surgery Inflammation Market Growth to Accelerate in Forecast Period (2023-2032), DelveInsight Analyzes | Mallinckrodt Pharma, Salix Pharma, GlaxoSmithKline, Pfizer Inc.
DelveInsight's "Post-operative Cataract Surgery Inflammation Market Insights, Epidemiology, and Market Forecast-2032 report offers an in-depth understanding of the Post-operative Cataract Surgery Inflammation, historical and forecasted epidemiology as well as the Post-operative Cataract Surgery Inflammation market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Post-operative Cataract Surgery Inflammation market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Post-operative Cataract Surgery Inflammation Market Forecast [https://www.delveinsight.com/sample-request/post-operative-cataract-surgery-inflammation-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Some of the key facts of the Post-operative Cataract Surgery Inflammation Market Report:
*
The Post-operative Cataract Surgery Inflammation market size is anticipated to grow with a significant CAGR during the study period (2019-2032)
*
In December 2024, VivaVision Biotech, a clinical-stage, privately owned biotechnology company dedicated to developing therapies for ocular diseases, today revealed positive topline results from its U.S. Phase 2 clinical trial of VVN461-CS-201. This potent non-steroidal dual JAK1/TYK2 immunomodulator is being developed to treat post-operative inflammation following cataract surgery.
*
In December 2024, VivaVision Biotech, based in China, plans to move forward with its non-steroidal therapy, VVN461-CS-201 (VVN461), into a Phase III trial after the candidate successfully met the primary endpoint in a Phase II U.S. study focused on treating post-operative inflammation following cataract surgery.
*
There are around 10 million cataract procedures conducted each year to treat the estimated 95 million people who have them worldwide. As a result, cataract surgery is among the most frequently carried out medical treatments worldwide. After cataract surgery, postoperative inflammation is a typical consequence
*
According to the American Academy of Ophthalmology (2023), more than 24.4 million Americans aged 40 and older have cataracts. About half of all Americans have cataracts by the age of 75
*
The National Eye Institute (2020) reports that the US had a 17.11% prevalence of cataracts in 2010. More over half of all Americans 80 years of age and older either have cataracts or have undergone cataract surgery
*
Key Post-operative Cataract Surgery Inflammation Companies: Mallinckrodt Pharmaceuticals, Salix Pharmaceuticals, GlaxoSmithKline plc., Pfizer Inc., ASKA Pharmaceutical Co., Ltd., Bausch Health, Johnson & Johnson Services, Inc., Janssen Global Services, Takeda Pharmaceutical Company Limited, Merck & Co., Inc., Oculis, Formosa Pharmaceuticals, AimMaxTherapeutics, Salvat Laboratories, Azidus Brasil, Bausch & Lomb Incorporated, Laboratorios Poen, Oculis, Alcon Research, and others
*
Key Post-operative Cataract Surgery Inflammation Therapies: OCS-01, APP13007, SVT15473, Ster, Bromfenac, Difluprednate, OCS-01 - Dexamethasone, Nepafenac Ophthalmic Suspension, and others
*
The Post-operative Cataract Surgery Inflammation epidemiology based on gender analyzed that females were more affected by cataract than men
*
The Post-operative Cataract Surgery Inflammation market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Post-operative Cataract Surgery Inflammation pipeline products will significantly revolutionize the Post-operative Cataract Surgery Inflammation market dynamics.
Post-operative Cataract Surgery Inflammation Overview
A cataract is a clouded spot in the eye's lens, which is clear and helps to concentrate light. Cataracts are quite frequent in older people. In actuality, more than half of all Americans 80 years of age and older either have cataracts or have undergone cataract surgery. Additionally, it is the leading global cause of blindness.
Get a Free sample for the Post-operative Cataract Surgery Inflammation Market Report
https://www.delveinsight.com/report-store/post-operative-cataract-surgery-inflammation-market [https://www.delveinsight.com/report-store/post-operative-cataract-surgery-inflammation-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Post-operative Cataract Surgery Inflammation Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.
Post-operative Cataract Surgery Inflammation Epidemiology Segmentation:
The Post-operative Cataract Surgery Inflammation market report proffers epidemiological analysis for the study period 2019-2032 in the 7MM segmented into:
*
Total Prevalence of Post-operative Cataract Surgery Inflammation
*
Prevalent Cases of Post-operative Cataract Surgery Inflammation by severity
*
Gender-specific Prevalence of Post-operative Cataract Surgery Inflammation
*
Diagnosed Cases of Episodic and Chronic Post-operative Cataract Surgery Inflammation
Download the report to understand which factors are driving Post-operative Cataract Surgery Inflammation epidemiology trends @ Post-operative Cataract Surgery Inflammation Epidemiology Forecast [https://www.delveinsight.com/sample-request/post-operative-cataract-surgery-inflammation-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Post-operative Cataract Surgery Inflammation Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Post-operative Cataract Surgery Inflammation market or expected to get launched during the study period. The analysis covers Post-operative Cataract Surgery Inflammation market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Post-operative Cataract Surgery Inflammation Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Post-operative Cataract Surgery Inflammation Therapies and Key Companies
*
OCS-01: Oculis
*
APP13007: Formosa Pharmaceuticals/AimMaxTherapeutics
*
SVT15473: Salvat Laboratories
*
Ster: Azidus Brasil
*
Bromfenac: Bausch & Lomb Incorporated
*
Difluprednate: Laboratorios Poen
*
OCS-01 - Dexamethasone: Oculis
*
Nepafenac Ophthalmic Suspension: Alcon Research
Discover more about therapies set to grab major Post-operative Cataract Surgery Inflammation market share @ Post-operative Cataract Surgery Inflammation Treatment Market [https://www.delveinsight.com/sample-request/post-operative-cataract-surgery-inflammation-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Post-operative Cataract Surgery Inflammation Market Strengths
*
Advances in surgical techniques
*
Advances in the understanding of ophthalmology
*
Pipeline consists of late and early stage candidates.
Post-operative Cataract Surgery Inflammation Market Opportunities
*
Uptake of potential emerging therapies with better clinical profile expected to be medium-fast due to the present unmet needs
*
The side effects associated with therapies currently give a window of opportunity to pharma payer to bring in novel therapies.
Scope of the Post-operative Cataract Surgery Inflammation Market Report
*
Study Period: 2019-2032
*
Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
*
Key Post-operative Cataract Surgery Inflammation Companies: Mallinckrodt Pharmaceuticals, Salix Pharmaceuticals, GlaxoSmithKline plc., Pfizer Inc., ASKA Pharmaceutical Co., Ltd., Bausch Health, Johnson & Johnson Services, Inc., Janssen Global Services, Takeda Pharmaceutical Company Limited, Merck & Co., Inc., Oculis, Formosa Pharmaceuticals, AimMaxTherapeutics, Salvat Laboratories, Azidus Brasil, Bausch & Lomb Incorporated, Laboratorios Poen, Oculis, Alcon Research, and others
*
Key Post-operative Cataract Surgery Inflammation Therapies: OCS-01, APP13007, SVT15473, Ster, Bromfenac, Difluprednate, OCS-01 - Dexamethasone, Nepafenac Ophthalmic Suspension, and others
*
Post-operative Cataract Surgery Inflammation Therapeutic Assessment: Post-operative Cataract Surgery Inflammation current marketed and Post-operative Cataract Surgery Inflammation emerging therapies
*
Post-operative Cataract Surgery Inflammation Market Dynamics: Post-operative Cataract Surgery Inflammation market drivers and Post-operative Cataract Surgery Inflammation market barriers
*
Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
*
Post-operative Cataract Surgery Inflammation Unmet Needs, KOL's views, Analyst's views, Post-operative Cataract Surgery Inflammation Market Access and Reimbursement
To know more about Post-operative Cataract Surgery Inflammation companies working in the treatment market, visit @ Post-operative Cataract Surgery Inflammation Clinical Trials and Therapeutic Assessment [https://www.delveinsight.com/sample-request/post-operative-cataract-surgery-inflammation-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Table of Contents
1. Post-operative Cataract Surgery Inflammation Market Report Introduction
2. Executive Summary for Post-operative Cataract Surgery Inflammation
3. SWOT analysis of Post-operative Cataract Surgery Inflammation
4. Post-operative Cataract Surgery Inflammation Patient Share (%) Overview at a Glance
5. Post-operative Cataract Surgery Inflammation Market Overview at a Glance
6. Post-operative Cataract Surgery Inflammation Disease Background and Overview
7. Post-operative Cataract Surgery Inflammation Epidemiology and Patient Population
8. Country-Specific Patient Population of Post-operative Cataract Surgery Inflammation
9. Post-operative Cataract Surgery Inflammation Current Treatment and Medical Practices
10. Post-operative Cataract Surgery Inflammation Unmet Needs
11. Post-operative Cataract Surgery Inflammation Emerging Therapies
12. Post-operative Cataract Surgery Inflammation Market Outlook
13. Country-Wise Post-operative Cataract Surgery Inflammation Market Analysis (2019-2032)
14. Post-operative Cataract Surgery Inflammation Market Access and Reimbursement of Therapies
15. Post-operative Cataract Surgery Inflammation Market Drivers
16. Post-operative Cataract Surgery Inflammation Market Barriers
17. Post-operative Cataract Surgery Inflammation Appendix
18. Post-operative Cataract Surgery Inflammation Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.
Media Contact
Company Name: DelveInsight
Contact Person: Gaurav Bora
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=postoperative-cataract-surgery-inflammation-market-growth-to-accelerate-in-forecast-period-20232032-delveinsight-analyzes-mallinckrodt-pharma-salix-pharma-glaxosmithkline-pfizer-inc]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Post-operative Cataract Surgery Inflammation Market Growth to Accelerate in Forecast Period (2023-2032), DelveInsight Analyzes | Mallinckrodt Pharma, Salix Pharma, GlaxoSmithKline, Pfizer Inc. here
News-ID: 3976525 • Views: …
More Releases from ABNewswire
Red Teaming vs Penetration Testing: Understanding the Difference
Image: https://www.abnewswire.com/upload/2025/12/bc1e8a773c50dd0c9305d06207de098f.jpg
The topic of red teaming vs penetration testing often creates confusion among security teams, decision-makers and technical stakeholders. Both approaches aim to uncover weaknesses, yet they work in very different ways. Many organisations rely on one method thinking it covers the role of the other. This misunderstanding can lead to gaps in visibility, unclear expectations and misplaced confidence.
A clearer view of pentest vs red team helps organisations make better…
Suburban Solutions Moving Announces New West Chester, PA Location to Strengthen …
West Chester, PA - Suburban Solutions [https://suburbansolutions.com/], a highly trusted and fast-growing moving company serving the Greater Philadelphia and Washington, DC regions, is proud to announce the opening of its newest location at 1271 Upton Cir, West Chester, PA 19380. This expansion marks an important step in the company's ongoing mission to provide dependable and accessible relocation support to more communities across Pennsylvania.
With this new branch, Suburban Solutions Moving aims…
LSLONG Launches New Premium Custom Polo Shirt Collection with Full OEM & ODM Sup …
Shenzhen LSLONG Garments Co., Ltd., a global leader in apparel manufacturing, has officially unveiled its new Premium Custom Polo Shirt [https://www.lslt-shirt.com/polo-shirt-categories/] Collection, combining advanced fabrics, innovative designs, and end-to-end customization solutions. This launch underscores LSLONG's 25 years of experience delivering high-quality OEM and ODM apparel services to brands across more than 50 countries. The collection aims to empower brands with versatile, stylish, and performance-driven Polo shirts while providing comprehensive support…
Arteestry Creations Plus Brings Unique Customizable Designs to Over 50 Product C …
Arteestry Creations Plus offers creative custom designs across an extensive range of products from apparel to home goods to magnets, serving customers seeking personalized items for holidays, special occasions, and everyday use. The growing e-commerce brand combines artistic creativity with broad product versatility, featuring licensed collections from Disney, Pixar, Marvel, and Star Wars alongside original designs that can be applied across different product types upon customer request.
Arteestry Creations Plus has…
More Releases for Cataract
Transformative Trends Impacting the Cataract Surgery Devices And Equipment Marke …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Cataract Surgery Devices And Equipment Market Size By 2025?
The market size for cataract surgery devices and equipment has shown a consistent growth trend in recent years. It is projected to increase from $13.97 billion in 2024 to $14.52 billion in 2025, exhibiting a compound…
Cataract Pipeline: Emerging Non-Surgical Solutions and Leading Companies Shaping …
The therapeutic landscape for Cataract, the leading cause of blindness globally, is undergoing a paradigm shift as researchers and biopharmaceutical companies explore non-surgical and disease-modifying alternatives to conventional cataract extraction surgery. Advances in molecular biology, oxidative stress modulation, and crystallin protein stabilization have opened new avenues for pharmacological intervention. Companies like Nacuity Pharmaceuticals, CGeneTech, and Plex Pharmaceuticals are pioneering efforts to develop novel agents aimed at delaying, halting, or reversing…
Cataract Surgery Devices Market - Innovation Meets Precision: Elevate Cataract S …
Newark, New Castle, USA: The "Cataract Surgery Devices Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Cataract Surgery Devices Market: https://www.growthplusreports.com/report/cataract-surgery-devices-market/7846
This latest report researches the industry structure,…
Intraocular Lens Implants for Cataract Market is Driven by the Increasing Incide …
The proposed Intraocular Lens Implants for Cataract Market report will encompass all the qualitative & quantitative aspects including the market size, market estimates, growth rates & forecasts & hence will give you a holistic view of the market. The study also includes detailed analysis of market drivers, restraints, technological advancements & competitive landscape along with various micro & macro factors influencing the market dynamics.
The Intraocular Lens Implants for Cataract Market…
Potential Opportunities of Cataract Surgical Devices Market
The global cataract surgical devices market size is projected to reach USD 9.98 billion by the end of 2026. The high prevalence of cataract disorders will open up a huge potential for market growth. According to a report published by Fortune Business Insights, titled "Cataract Surgical Devices Market Size, Share & Industry Analysis, By Product Type (Phacoemulsification Systems, Femtosecond Laser, Intraocular Lenses, Ophthalmic Viscoelastic Devices & Other Consumables), By End-user…
Cataract Surgery Devices Market Opportunity Analysis, 2018-2026
Cataract surgery devices are used during the surgical procedures to treat cataract, which is an eye disorder that causes clouding of the lens leading to defects in vision. Cataract is one of the most widespread disease causing blindness and it reduces vision ability. Cataract is often encountered to develop slowly and affect either one or both the eyes.
Although cataract does not interfere with the eyesight in the early stages, it…
